Title

Race and Regulation Podcast Episode 6 - Race, Social Inequalities, and Clinical Drug Trials

Authors

Jill A. Fisher, University of North Carolina, Chapel Hill

Document Type

Article

Publication Date

7-6-2022

Abstract

As mandated by the U.S. Food and Drug Administration, clinical trials for new pharmaceuticals enroll healthy people as paid research participants to test for drug safety and tolerability. But the social injustices from these trials are too often overlooked. Drawing on her award-winning book, Adverse Events, Jill Fisher of UNC-Chapel Hill’s Center for Bioethics explains how clinical drug trials attract disproportionate participation by racial and ethnic minorities who then disproportionately assume risks of participating in these trials, often just to stay financially afloat.

Comments

Hosted by Cary Coglianese, Director of the Penn Program on Regulation.

Produced by Patty McMahon

Music by Joy Ike

Recommended Citation

Fisher, Jill A., "Race and Regulation Podcast Episode 6 - Race, Social Inequalities, and Clinical Drug Trials" (2022). Penn Program on Regulation Podcasts. 6.
https://scholarship.law.upenn.edu/ppr-podcasts/6